EGT0001442
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EGT0001442, covering 2011-07-20 to 2021-06-16. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus [Phase 2]